Rx Manufacturers Taking Closer Look At Vendors' Corporate Compliance
Executive Summary
Pharmaceutical manufacturers are beginning to look more closely at the compliance policies of their vendors, participants in a Sept. 21 audio conference sponsored by the Food & Drug Law Institute said.
You may also be interested in...
Rx Marketing Compliance Programs “Ramping Up” After TAP – Prosecutor
Pharmaceutical manufacturers appear to be taking marketing compliance programs more seriously following the TAP settlement, Philadelphia Assistant U.S. Attorney James Sheehan told a Health Care Compliance Association teleconference Dec. 14
Rx Marketing Compliance Programs “Ramping Up” After TAP – Prosecutor
Pharmaceutical manufacturers appear to be taking marketing compliance programs more seriously following the TAP settlement, Philadelphia Assistant U.S. Attorney James Sheehan told a Health Care Compliance Association teleconference Dec. 14
Rx Industry IG Compliance Group Supports FDA Systems Model For Audits
The "Ad Hoc OIG Compliance Group" will advocate the "systems-based" auditing approach recommended by FDA when it meets with the HHS Inspector General to discuss a pharmaceutical industry compliance policy guidance.